West pharmaceutical services reports q2 adj eps of $1.25

West announces second-quarter 2020 results.q2 adjusted earnings per share $1.25.q2 earnings per share $1.21.q2 earnings per share estimate $0.91 -- refinitiv ibes data.sees fy 2020 sales $2.035 billion to $2.055 billion.q2 sales $527.2 million versus refinitiv ibes estimate of $496.1 million.raising full-year 2020 adjusted-diluted eps guidance to a new range of between $4.15 and $4.25.sees 2020 organic sales growth to be approximately 12%.west pharmaceutical services - net sales guidance includes estimated full-year headwind of $26 million for 2020 based on current foreign exchange rates.fy2020 earnings per share view $3.64, revenue view $1.97 billion -- refinitiv ibes data.
WST Ratings Summary
WST Quant Ranking